跳至主要内容
临床试验/EUCTR2009-012847-40-GB
EUCTR2009-012847-40-GB进行中(未招募)1 期

A Randomised Study Comparing Two Different Regimens of Ovarian Stimulation Using Pergoveris and Cetrorelix for Controlled Ovarian Superovulation in Assisted Conception Treatment. - Pergoveris and Cetrorelix for controlled ovarian stimulation

HS Lothian0 个研究点目标入组 80 人开始时间: 2009年10月20日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
80

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

入选标准

  • -healthy female;
  • -aged 21 – 38 years;
  • - undergoing IVF treatment for unexplained, tubal or male factor subfertility;
  • -regular menstrual cycles (24-35 days);
  • -both ovaries present (no previous surgery on ovaries);
  • -able to understand protocol;
  • -able to give informed consent.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • -polycystic ovarian syndrome
  • -endometriosis (severe) requiring treatment;
  • -serum AMH level < 6 pmol/l at screening;
  • -known history of poor ovarian response during assisted conception treatment;
  • -3 or more failed IVF/ICSI cycles (defined as failure to achieve pregnancy and live birth);
  • -allergic to investigational compounds;
  • -contraindication to any of the study medication
  • -lactation;
  • -use of depot hormonal contraceptive within a period of six months or use of oral contraceptive within eight weeks prior to start of COS treatment;
  • -hypertension (systolic >155 mm Hg; diastolic >90mmHg);
  • -history of alcohol or drug abuse;
  • -abnormal biochemistry/haematology results at screening;
  • -administration of investigational drugs within 20 days of Screening
  • -not able to give informed consent.

研究者

发起方
HS Lothian

相似试验

A Randomised Study Comparing Two Different Regimens... | 临床试验